Literature DB >> 31228104

No effect of acidification or freezing on urinary metanephrine levels.

L C Pinto1, C K Kramer2, J L Camargo3, L H Canani3, J L Gross3, C B Leitão3.   

Abstract

BACKGROUND: Urinary metanephrine is a reliable method to estimate catecholamine secretion. Traditionally, urinary metanephrines are collected into chilled containers containing hydrochloric acid (HCl) and most laboratories freeze urinary samples before analysis. It is uncertain if these pre-analytic procedures alter metanephrine values. AIM: To evaluate if acidifying and freezing urine samples affect the accuracy of urinary metanephrine measurements.
METHODS: Random urine samples from healthy individuals were collected. Urine samples were distributed into two containers: with HCl 50% homogenized with urine to obtain pH < 2, and without HCl. Each container was divided again into aliquots for immediate measurement or freezing. One aliquot with acid (group 1) and another without acid (group 2) were sent immediately to the laboratory for testing (HPLC), while the other two aliquots, one with acid (group 3) and another without it (group 4) were frozen for 3 months at - 20 °C. Bland-Altman's test was used to analyze inter-assay agreement between measurements.
RESULTS: A total of 15 individuals were included (mean age 27.5 ± 5.9 years, 8 male and 14 white). No difference was observed on mean urinary metanephrine/creatinine ratio between groups: group 1: 0.23 ± 0.11, group 2: 0.22 ± 0.07, group 3: 0.25 ± 0.13, group 4: 0.25 ± 0.15 mg/g creatinine; P > 0.05 for all the comparisons). Bland-Altman's analysis showed agreement between the standard method (group 1) and the experimental method (group 4).
CONCLUSION: Measurement of urinary metanephrines by HPLC method is not influenced by sample acidification nor freezing at - 20 °C for 3 months.

Entities:  

Keywords:  Acidification; Freezing; Urinary metanephrines

Year:  2019        PMID: 31228104     DOI: 10.1007/s40618-019-01076-9

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  21 in total

1.  Effects of drugs on glucose measurements with handheld glucose meters and a portable glucose analyzer.

Authors:  Z Tang; X Du; R F Louie; G J Kost
Journal:  Am J Clin Pathol       Date:  2000-01       Impact factor: 2.493

Review 2.  Insulin assays and reference values.

Authors:  D Chevenne; F Trivin; D Porquet
Journal:  Diabetes Metab       Date:  1999-12       Impact factor: 6.041

Review 3.  Phaeochromocytoma.

Authors:  Jacques W M Lenders; Graeme Eisenhofer; Massimo Mannelli; Karel Pacak
Journal:  Lancet       Date:  2005 Aug 20-26       Impact factor: 79.321

Review 4.  Pheochromocytoma.

Authors:  N L Benowitz
Journal:  Adv Intern Med       Date:  1990

5.  Biochemical diagnosis of pheochromocytoma: which test is best?

Authors:  Jacques W M Lenders; Karel Pacak; McClellan M Walther; W Marston Linehan; Massimo Mannelli; Peter Friberg; Harry R Keiser; David S Goldstein; Graeme Eisenhofer
Journal:  JAMA       Date:  2002-03-20       Impact factor: 56.272

6.  Pheochromocytoma with predominant epinephrine secretion.

Authors:  L B Page; J W Raker; F R Berberich
Journal:  Am J Med       Date:  1969-10       Impact factor: 4.965

Review 7.  Diagnosis of a pheochromocytoma.

Authors:  Sydney A Westphal
Journal:  Am J Med Sci       Date:  2005-01       Impact factor: 2.378

8.  Biochemical diagnosis of pheochromocytoma by simultaneous measurement of urinary excretion of epinephrine and norepinephrine.

Authors:  G A Smythe; G Edwards; P Graham; L Lazarus
Journal:  Clin Chem       Date:  1992-04       Impact factor: 8.327

9.  Chromogranin A storage and secretion: sensitivity and specificity for the diagnosis of pheochromocytoma.

Authors:  R J Hsiao; R J Parmer; M A Takiyyuddin; D T O'Connor
Journal:  Medicine (Baltimore)       Date:  1991-01       Impact factor: 1.889

10.  Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline.

Authors:  Jacques W M Lenders; Quan-Yang Duh; Graeme Eisenhofer; Anne-Paule Gimenez-Roqueplo; Stefan K G Grebe; Mohammad Hassan Murad; Mitsuhide Naruse; Karel Pacak; William F Young
Journal:  J Clin Endocrinol Metab       Date:  2014-06       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.